Search Articles

RDD Europe 2011 (2011)

ISBN: Book 1: 1-933722-50-9; Book 2: 1-933722-51-7

Editors: Dalby, RN, Byron, PR, Peart, J, Suman, JD and Young, PM

Copyright© 2011 by Virginia Commonwealth University. All rights reserved. Subject to fair use provisions of United States Copyright Law, no part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without written permission from Virginia Commonwealth University, Richmond, VA. Please address permission requests or inquiries about excerpted or customized reprints of five or more copies to RDD Online.

Showing 1-10 of 89 article(s)

1. Genetics and Environment: Their Influence on Rational Drug Therapy for Asthma
Custovic A, Simpson A
RDD Europe 2011. Volume 1, 2011: 1-10.

2. The Discovery of Vilanterol Based on Structure-Activity Relationships (SAR) and the Antedrug Approach
Procopiou PA
RDD Europe 2011. Volume 1, 2011: 11-20.

3. Indacaterol: Ultra LABA Selection and Properties - A Pharmacologic Viewpoint
Trifilieff A
RDD Europe 2011. Volume 1, 2011: 21-28.

4. Efficacy and Safety of ASM8: An Anticytokine Oligonucleotide Combination in Allergic Asthmatics
Gauvreau GM, O'Byrne PM
RDD Europe 2011. Volume 1, 2011: 29-40.

5. Liposomes, Niosomes and Proniosomes - A Critical Update of Their Development as Inhaled Products
Cipolla DC, Redelmeier T, Eastman SJ, Bruinenberg P, Gonda I
RDD Europe 2011. Volume 1, 2011: 41-54.

6. Device Engineering Insights into TOBI Podhaler: A Development Case Study of High Efficiency Powder Delivery to Cystic Fibrosis Patients
Maltz DS, Paboojian SJ
RDD Europe 2011. Volume 1, 2011: 55-66.

7. Truth in Sizing Electrostatic Effects and Cascade Impactors
Mohan M, Vinchurkar SC, Longest P, Byron PR, Peart J
RDD Europe 2011. Volume 1, 2011: 67-78.

8. In Vitro Techniques Equipped to Study Clinically Relevant Controlled Release Products
Young PM, Traini D, Salama RO
RDD Europe 2011. Volume 1, 2011: 79-88.

9. Predicting HFA-MDI Dose Retention Properties: Engineering the Marriage between Canisters, Valves and Formulations
Lewis DA, O'Shea H, Johnson R, Church T
RDD Europe 2011. Volume 1, 2011: 89-100.

10. A New Co-Suspension MDI Platform: Scientific Foundations of Mono, Dual and Triple Combination Products
Lechuga-Ballesteros D, Vehring R, Dwivedi SK
RDD Europe 2011. Volume 1, 2011: 101-112.